Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 173
Titolo Tipologia Data di pubblicazione Autori File
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database 01 - Articolo su rivista 2024 Cortinovis, DiegoPagni, Fabio +
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed 01 - Articolo su rivista 2024 Cortinovis, Diego Luigi +
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma 01 - Articolo su rivista 2024 Cortinovis, Diego +
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 01 - Articolo su rivista 2024 Villa, MatteoMalighetti, FedericaManfroni, ChiaraFontana, DilettaCordani, NicolettaMeneveri, RaffaellaPiazza, RoccoPagni, FabioCortinovis, DiegoMologni, Luca +
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting 01 - Articolo su rivista 2024 Seminati, DavideL'Imperio, VincenzoCasati, GabrielePilla, DanielaCortinovis, Diego LuigiBono, FrancescaPagni, Fabio +
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program 01 - Articolo su rivista 2024 Cortinovis, Diego +
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective 01 - Articolo su rivista 2023 Cordani N.Bianchi T.Cortinovis D. L.Cazzaniga M. E.Lissoni A. A.Landoni F. +
A cross-sectional analysis of treatment patterns in small-cell lung cancer in five European countries 01 - Articolo su rivista 2023 Cortinovis, D +
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study 01 - Articolo su rivista 2023 Cortinovis, D +
Novel Therapeutic Options for Small Cell Lung Cancer 01 - Articolo su rivista 2023 Abbate, MIBianchi, SPCortinovis, DL +
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer 01 - Articolo su rivista 2023 Diego Cortinovis +
Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel Discussion 01 - Articolo su rivista 2023 Cortinovis, DL +
VITAMIN D SUPPLEMENTATION MAY IMPROVE COVID-19 PROGNOSIS? EVIDENCE FROM A SYSTEMATIC REVIEW AND META-ANALYSIS 01 - Articolo su rivista 2022 Chiocca, SCortinovis, DChiaradonna, FPalorini, RFacciotti, F +
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 02 - Intervento a convegno 2022 Villa, MMalighetti, FArosio, GManfroni, CFontana, DCordani, NMeneveri, RZambon, APiazza, RPagni, FCortinovis, DMologni, L +
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 01 - Articolo su rivista 2022 Laffusa, AliceScaravaglio, MikiCristoferi, LauraCiaccio, AntonioCortinovis, Diego LuigiInvernizzi, PietroMassironi, Sara +
A Cast of Shadow on Postoperative Radiotherapy for pIIIA-N2 Non-Small Cell Lung Cancer? 01 - Articolo su rivista 2022 Arcangeli, SCortinovis, D +
Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma 01 - Articolo su rivista 2022 Cortinovis D. L.Pagni F. +
Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy 01 - Articolo su rivista 2022 Cortinovis D +
RNA-based next-generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 01 - Articolo su rivista 2022 Pagni F.Cortinovis D. L. +
Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis 01 - Articolo su rivista 2022 Chiocca S.Cortinovis D.Chiaradonna F.Palorini R.Zerbato B. +
Mostrati risultati da 1 a 20 di 173
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile